Sanofi: all 2,424 studies
Page 20 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With HypertensionCompletedNCT00529750Phase 4
- Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes MellitusCompletedNCT00526513Phase 4
- Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of AgeCompletedNCT00524732
- Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or ErlotinibCompletedNCT00522145Phase 2
- Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck CancerCompletedNCT00521521Phase 2
- Alglucosidase Alfa Temporary Access ProgramApproved for marketingNCT00520143
- Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline GlargineCompletedNCT00518427Phase 4
- Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in ArgentinaCompletedNCT00507845Phase 4
- Phase I Irinotecan, 5-Fluorouracil and Leucovorin CombinationCompletedNCT00507091Phase 1
- ZD6474(Vandetanib) + Alimta Combo StudyCompletedNCT00506051Phase 1
- Phase I Chinese PKCompletedNCT00503711Phase 1
- Dose-effect of SSR180575 in Diabetic NeuropathyCompletedNCT00502515Phase 2
- Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic AscitesCompletedNCT00501722Phase 2
- Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic AscitesCompletedNCT00501566Phase 2
- Satavaptan Dose-Ranging Study in the Prevention of AscitesCompletedNCT00501384Phase 2
- Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate HypertensionCompletedNCT00500604Phase 4
- Phase I FOLFOX CombinationCompletedNCT00499850Phase 1
- A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal DiseaseTerminatedNCT00498212Phase 2
- Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)CompletedNCT00497783Phase 4
- Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)CompletedNCT00497692Phase 4
- Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal CancerCompletedNCT00496509Phase 1
- Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCCompletedNCT00496275Phase 1
- Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes MellitusCompletedNCT00495885Phase 3
- MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary TuberculosisCompletedNCT00495339Phase 4
- Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate CancerTerminatedNCT00494338Phase 2
- Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in ChildrenCompletedNCT00491985Phase 2
- A Study of the Immunogenicity and Safety of the 2007-2008 Influenza VaccineCompletedNCT00491257Phase 2
- APIDRA Registration StudyCompletedNCT00489190Phase 4
- DOMME Dose Optimization Multicentric Mexican EvaluationCompletedNCT00488527Phase 4
- SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCompletedNCT00486785Phase 4
- Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or LymphomaCompletedNCT00486135Phase 1
- Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer PatientsCompletedNCT00485979Phase 2
- Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid TumorsCompletedNCT00485719Phase 1
- Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster DoseCompletedNCT00483470Phase 3
- Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese PatientsCompletedNCT00481975Phase 3
- Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese PatientsCompletedNCT00481923Phase 3
- A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer PatientsCompletedNCT00479076Phase 1
- Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and ExerciseTerminatedNCT00478972Phase 3
- Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic DrugTerminatedNCT00478595Phase 3
- Gulf Evaluation of VAlproate (Depakine Chrono) in maNia StudyCompletedNCT00477373Phase 4
- Practicability and Acceptability of Stylomax® in ChildrenCompletedNCT00476385Phase 3
- Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma PatientsCompletedNCT00471965Phase 3
- Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes MellitusCompletedNCT00467376Phase 3
- A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated DiarrheaTerminatedNCT00466635Phase 3
- Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox VaccineCompletedNCT00466245Phase 2
- Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)CompletedNCT00464633Phase 2
- Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGSCompletedNCT00464321Phase 1
- Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking CessationCompletedNCT00464256Phase 3
- Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic StudyCompletedNCT00464243Phase 3
- Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking CessationCompletedNCT00464165Phase 3
- Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes MellitusTerminatedNCT00464061Phase 3
- A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® InjectionCompletedNCT00463021Phase 4
- Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerTerminatedNCT00461344Phase 2
- SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.CompletedNCT00460733Phase 4
- Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking CessationCompletedNCT00459173Phase 3
- Japanese Dose-Response Study of Rimonabant in Obese PatientsCompletedNCT00459004Phase 2
- Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine PatchCompletedNCT00458718Phase 3
- Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk FactorsTerminatedNCT00458081Phase 3
- Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy AdultsCompletedNCT00457509Phase 1
- ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in ChildrenCompletedNCT00457353Phase 3
- Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and RibavirinTerminatedNCT00456248Phase 4
- ALF-STONE: Alfuzosin in Uretheric StonesTerminatedNCT00454402Phase 3
- A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on HemodialysisCompletedNCT00454350Phase 4
- Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic PatientsCompletedNCT00454272Phase 4
- Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular GoiterCompletedNCT00454220Phase 2
- Alfuzosin Versus Placebo in Acute Urinary RetentionTerminatedNCT00453908Phase 3
- Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 MonthsCompletedNCT00453570Phase 3
- Risedronate Sodium in Post Menopausal OsteoporosisCompletedNCT00453492Phase 4
- Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian CancerCompletedNCT00452985
- ACT MALI: Treatment of Malaria Based on Combination TherapiesCompletedNCT00452907Phase 4
- Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's SyndromeCompletedNCT00452725Phase 3
- MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal ChildrenCompletedNCT00452491Phase 3
- Objective Study in Rheumatoid ArthritisCompletedNCT00451971Phase 4
- Open Label, Phase I ZD6474 Head and Neck Cancer StudyCompletedNCT00450138Phase 1
- A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 DiabetesTerminatedNCT00449605Phase 3
- REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old ChildrenCompletedNCT00447525Phase 3
- Preventing Antibiotic-Associated DiarRhea Using ErcefloraCompletedNCT00447161Phase 4
- Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLeranceCompletedNCT00445796Phase 4
- Irbesartan/Hydrochlorothiazide National Taiwan University Hospital ListingCompletedNCT00443612Phase 4
- Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial DiseaseCompletedNCT00443287Phase 2
- Cross-Over Study of Sevelamer Hydrochloride and Sevelamer CarbonateCompletedNCT00440648Phase 2
- A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate HypercholesterolemiaCompletedNCT00440154Phase 2
- Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in SchizophreniaTerminatedNCT00439634Phase 2
- Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) InhibitorCompletedNCT00437463Phase 3
- Taxotere Prostate Cancer New Indication Registration Trial in ChinaCompletedNCT00436839Phase 3
- Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00436800Phase 2
- Amisulpride in Schizophrenic Acute Phase PatientsCompletedNCT00436371Phase 4
- Taxotere + Cisplatin in Nasopharyngeal CarcinomaCompletedNCT00436293Phase 2
- Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.CompletedNCT00434681Phase 3
- Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)TerminatedNCT00434096Phase 3
- Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive DisorderCompletedNCT00432614Phase 3
- Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE)CompletedNCT00432575Phase 2
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00432315Phase 2
- Valproic Acid Sodium Salt in Bipolar DisorderCompletedNCT00431522Phase 4
- A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With DepressionCompletedNCT00429260Phase 3
- Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure PatientsCompletedNCT00426712Phase 1
- Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)CompletedNCT00425243Phase 3
- Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.CompletedNCT00425191Phase 2
- DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic EffectCompletedNCT00424905Phase 4
- ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)CompletedNCT00424853Phase 2